Funding, News and Announcements

​BioCanRx has set the next intake date for funding applications in ​their rolling, open call process. BioCanRx builds on past and ongoing investments in the area of cancer biotherapeutics that have a clear path to, or are ready for, clinical trials. ​The network is strengthening Canada's ability to translate the unfolding promise of immune-based cancer therapies into benefits for patients.
As an open call, this opportunity is open to all investigators located at Canadian institutions eligible to receive peer-reviewed funding from the three federal research-granting councils (CIHR, SSHRC, NSERC).

LOIs are now being accepted for the​ four research programs:

·         Clinical Trials Program
·         Enabling Studies Program
·         Catalyst Program
·         Clinical, Social and Economic Impact Program

If you have questions regarding your eligibility (or that of your institution) or how your project would fit within

​BioCanRx's research program, you are encouraged to contact Dr. Kelley Parato, Director of Scientific Affairs at BioCanRx.
 
Important Dates:
The next intake deadline is November 9, 2016, by 11:59 p.m. EDT.

Contact information: 
For more information, see the Apply for Funding page at the BioCanRx website or contact:
Dr. Kelley Parato
Tel: 613-739-6595

Email: keparato@biocanrx.com